Should beta blockers be abandoned as initial monotherapy in chronic open angle glaucoma? View 2.
Skuta
G L
GL
McGee Eye Institute, Department of Ophthalmology, University of Oklahoma College of Medicine, Oklahoma City, USA.
D000319:Adrenergic beta-Antagonists / Q000009:adverse effects / Q000627:therapeutic use*; D000959:Antihypertensive Agents / Q000009:adverse effects / Q000627:therapeutic use*; D002908:Chronic Disease; D005902:Glaucoma, Open-Angle / Q000188:drug therapy*; D006801:Humans
D000319:Adrenergic beta-Antagonists; D000959:Antihypertensive Agents